Research
Stifel Nicolaus Initiates Coverage on Evommune With Buy Rating, $54 Price Target
Evommune, Inc. (EVMN) has an average rating of Buy and mean price target of $52, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
$EVMN
